Insmed (INSM) Asset Writedowns and Impairment (2011)
Insmed (INSM) recorded quarterly Asset Writedowns and Impairment of $26.0 million in Q3 2011.
Insmed (INSM) Asset Writedowns and Impairment (2011) Analysis & Trends
Insmed's Asset Writedowns and Impairment history runs 1 years deep, the most recent figure standing at $26.0 million for Q3 2011.
- In Q3 2011, Asset Writedowns and Impairment changed N/A year-over-year to $26.0 million; the TTM figure through Dec 2012 stood at $26.0 million (changed 0.0% YoY), while the FY2011 annual figure was $26.0 million, changed N/A from the prior year.
- Asset Writedowns and Impairment was $26.0 million for Q3 2011 at Insmed.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $26.0 million in Q3 2011 to a low of $26.0 million in Q3 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Insmed | 19.79 Bn | 18.57 Bn | 258.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2011 | 25.99 Mn |
| Sep 30, 2011 | 25.99 Mn |